Latest & greatest articles for urinary tract infection

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on urinary tract infection or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on urinary tract infection and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for urinary tract infection

1. Point-of-Care Urine Dipstick Testing for Suspected Urinary Tract Infections for Adults: Diagnostic Accuracy

Point-of-Care Urine Dipstick Testing for Suspected Urinary Tract Infections for Adults: Diagnostic Accuracy Point-of-Care Urine Dipstick Testing for Suspected Urinary Tract Infections for Adults: Diagnostic Accuracy | CADTH.ca Find the information you need Point-of-Care Urine Dipstick Testing for Suspected Urinary Tract Infections for Adults: Diagnostic Accuracy Point-of-Care Urine Dipstick Testing for Suspected Urinary Tract Infections for Adults: Diagnostic Accuracy Last updated: February 15 (...) , 2019 Project Number: RA1013-000 Product Line: Research Type: Devices and Systems Report Type: Reference List Result type: Report Question What is the comparative diagnostic accuracy of point-of-care urine dipstick testing versus microscopic urinalysis in adult patients who present urinary tract infections in the emergency room or primary care setting? Key Message One systematic review and twp non-randomized studies were identified regarding point-of-care urine dipstick testing for suspected urinary

2019 Canadian Agency for Drugs and Technologies in Health - Rapid Review

2. Quantitative Results of a National Intervention to Prevent Hospital-Acquired Catheter-Associated Urinary Tract Infection: A Pre-Post Observational Study. (PubMed)

Quantitative Results of a National Intervention to Prevent Hospital-Acquired Catheter-Associated Urinary Tract Infection: A Pre-Post Observational Study. Many hospitals struggle to prevent catheter-associated urinary tract infection (CAUTI).To evaluate the effect of a multimodal initiative on CAUTI in hospitals with high burden of health care-associated infection (HAI).Prospective, national, nonrandomized, clustered, externally facilitated, pre-post observational quality improvement initiative (...) , for 3 cohorts active between November 2016 and May 2018.Acute care, long-term acute care, and critical access hospitals, including intensive care and non-intensive care wards.Target hospitals had a high burden of Clostridioides difficile infection plus central line-associated bloodstream infection, CAUTI, or hospital-onset methicillin-resistant Staphylococcus aureus bloodstream infection, defined as cumulative attributable differences above the first tertile in the Targeted Assessment for Prevention

2019 Annals of Internal Medicine

3. Fluoroquinolones for the Treatment of Urinary Tract Infection: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines

Fluoroquinolones for the Treatment of Urinary Tract Infection: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines Fluoroquinolones for the Treatment of Urinary Tract Infection: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines | CADTH.ca Find the information you need Fluoroquinolones for the Treatment of Urinary Tract Infection: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines Fluoroquinolones for the Treatment of Urinary Tract (...) Infection: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines Last updated: April 26, 2019 Project Number: RC1101-000 Product Line: Research Type: Drug Report Type: Summary with Critical Appraisal Result type: Report Question What is the clinical effectiveness of fluoroquinolones for the treatment of urinary tract infections? What is the cost-effectiveness of fluoroquinolones for the treatment of urinary tract infections? What are the evidence-based guidelines regarding the use

2019 Canadian Agency for Drugs and Technologies in Health - Rapid Review

4. Coated Catheters to Reduce Urinary Tract Infections: Clinical Effectiveness, Cost-Effectiveness, and Guidelines

Coated Catheters to Reduce Urinary Tract Infections: Clinical Effectiveness, Cost-Effectiveness, and Guidelines Coated Catheters to Reduce Urinary Tract Infections: Clinical Effectiveness, Cost-Effectiveness, and Guidelines | CADTH.ca Find the information you need Coated Catheters to Reduce Urinary Tract Infections: Clinical Effectiveness, Cost-Effectiveness, and Guidelines Coated Catheters to Reduce Urinary Tract Infections: Clinical Effectiveness, Cost-Effectiveness, and Guidelines Last (...) updated: April 30, 2019 Project Number: RB1323-000 Product Line: Research Type: Devices and Systems Report Type: Summary of Abstracts Result type: Report Question What is the clinical effectiveness of coated catheters compared to standard non-coated catheters for patients requiring long-term urinary catheter use for the prevention of urinary tract infections and blockage? What is the cost-effectiveness of coated catheters compared to standard non-coated catheters for patients requiring long-term

2019 Canadian Agency for Drugs and Technologies in Health - Rapid Review

5. UroShield for preventing catheter-associated urinary tract infections

UroShield for preventing catheter-associated urinary tract infections UroShield for pre UroShield for prev venting catheter-associated enting catheter-associated urinary tr urinary tract infections act infections Medtech innovation briefing Published: 9 September 2019 www.nice.org.uk/guidance/mib191 pathways Sum Summary mary The technology technology described in this briefing is UroShield. It is used to prevent catheter-associated urinary tract infections (CAUTI) in people with long-term (...) -of-rights). Page 1 of 11reduce the average number of CAUTIs per patient per year. The available evidence does not currently confirm that this would be the case. The technology The technology UroShield (NanoVibronix) is a disposable ultrasound device designed to reduce the risk of catheter- associated urinary tract infection (CAUTI). It reduces bacterial colonisation and biofilm formation on indwelling urinary catheters. UroShield should not be used for treating an active urinary infection

2019 National Institute for Health and Clinical Excellence - Advice

6. Urinary tract infection: diagnostic tools for primary care

Urinary tract infection: diagnostic tools for primary care Urinary tract infection: diagnostic tools for primary care - GOV.UK GOV.UK uses cookies to make the site simpler. Accept cookies You’ve accepted all cookies. You can at any time. Hide Search The United Kingdom is leaving the European Union on 31 October 2019. Guidance Urinary tract infection: diagnostic tools for primary care Quick reference materials for primary care on diagnosing and understanding culture results for urinary tract (...) and flowcharts for adults over-65 in the quick reference tool, which has been newly endorsed by NICE to follow guidance on managing catheter-associated urinary tract infections (CAUTI). 8 May 2019 Updated with revised UTI quick reference guide. 13 November 2018 Updated with revised UTI quick reference guide and flowcharts. 16 May 2018 Added link to the public consultation 'Diagnosis of urinary tract infections: quick reference guide'. 16 June 2017 Updated version of documents. 18 September 2014 Latest update

2019 Public Health England

7. Recurrent Uncomplicated Urinary Tract Infections in Women

Recurrent Uncomplicated Urinary Tract Infections in Women 1 Purpose Over the past few decades, our ability to diagnose, treat, and manage recurrent urinary tract infection (rUTI) long-term has evolved due to additional insights into the pathophysiology of rUTI, a new appreciation for the adverse effects of repetitive antimicrobial therapy (“collateral damage”), 1 rising rates of bacterial antimicrobial resistance, and better reporting of the natural history and clinical outcomes of acute (...) of urinary tract infections (UTIs) in the operative or procedural setting. In this document, the term UTI will refer to acute bacterial cystitis unless otherwise specified. This document seeks to establish guidance for the evaluation and management of patients with rUTIs to prevent inappropriate use of antibiotics, decrease the risk of antibiotic resistance, reduce adverse effects of antibiotic use, provide guidance on antibiotic and non-antibiotic strategies for prevention, and improve clinical outcomes

2019 American Urological Association

8. Imipenem, cilastatin and relebactam (Recarbrio) - To treat complicated urinary tract and complicated intra-abdominal infections

Imipenem, cilastatin and relebactam (Recarbrio) - To treat complicated urinary tract and complicated intra-abdominal infections Drug Approval Package: RECARBRIO U.S. Department of Health and Human Services Search FDA Submit search Drug Approval Package: RECARBRIO Company: Merck Sharp & Dohme Corp. Application Number: 212819 Approval Date: 07/16/2018 Persons with disabilities having problems accessing the PDF files below may call (301) 796-3634 for assistance. FDA Approval Letter and Labeling

2019 FDA - Drug Approval Package

9. Sodium-Glucose Cotransporter-2 Inhibitors and the Risk for Severe Urinary Tract Infections: A Population-Based Cohort Study. (PubMed)

Sodium-Glucose Cotransporter-2 Inhibitors and the Risk for Severe Urinary Tract Infections: A Population-Based Cohort Study. Prior studies evaluating risk for severe urinary tract infections (UTIs) with sodium-glucose cotransporter-2 (SGLT-2) inhibitors have reported conflicting findings.To assess whether patients initiating use of SGLT-2 inhibitors were at increased risk for severe UTI events compared with those initiating use of dipeptidyl peptidase-4 (DPP-4) inhibitors or glucagon-like

2019 Annals of Internal Medicine

10. Recurrent uncomplicated urinary tract infections in women: AUA/CUA/SUFU

Recurrent uncomplicated urinary tract infections in women: AUA/CUA/SUFU Recurrent Uncomplicated Urinary Tract Infections in Women: AUA/CUA/SUFU Guideline (2019) - American Urological Association advertisement Toggle navigation About Us About the AUA Membership AUA Governance Industry Relations Education AUAUniversity Education Products & Resources Normal Histology and Important Histo-anatomic Structures Urinary Bladder Prostate Kidney Renovascular Diseases Andrenal Gland Testis Paratesticular (...) Practice Resources Coding and Reimbursement Practice Managers' Network (PMN) Patient Safety and Quality of Care Accreditations and Reporting Patient Education Recurrent Uncomplicated Urinary Tract Infections in Women: AUA/CUA/SUFU Guideline (2019) Published 2019 [pdf] [pdf] Panel Members Jennifer Anger, MD, MPH; Una Lee, MD; A. Lenore Ackerman, MD, PhD; Roger Chou, MD; Bilal Chughtai, MD; J. Quentin Clemens, MD; Duane Hickling, MD, MSCI; Anil Kapoor, MD; Kimberly S. Kenton, MD, MS; Melissa R. Kaufman

2019 Canadian Urological Association

11. Pregnancy and lower urinary tract infection: opt for cefuroxime

Pregnancy and lower urinary tract infection: opt for cefuroxime Prescrire IN ENGLISH - Spotlight ''Pregnancy and lower urinary tract infection: opt for cefuroxime'', 1 April 2019 {1} {1} {1} | | > > > Pregnancy and lower urinary tract infection: opt for cefuroxime Spotlight Every month, the subjects in Prescrire’s Spotlight. 100 most recent :  |   |   |   |   |   |   |   |   |  Spotlight Pregnancy and lower urinary tract (...) infection: opt for cefuroxime Requiring just a single dose, fosfomycin trometamol is easier to take than cefuroxime or the combination of amoxicillin + clavulanic acid, but less is known about its short-term effects on the unborn child exposed during the first trimester of pregnancy. It is wiser to choose cefuroxime as first-line treatment. Minor lower urinary tract infections are frequent during pregnancy. They are routinely treated because they are a risk factor for premature birth. The first-choice

2019 Prescrire

12. Long-term antibiotics for preventing recurrent urinary tract infection in children. (PubMed)

Long-term antibiotics for preventing recurrent urinary tract infection in children. Urinary tract infection (UTI) is common in children. Symptoms include fever, lethargy, anorexia, and vomiting. UTI is caused by Escherichia coli in over 80% of cases and treatment is a course of antibiotics. Due to acute illness caused by UTI and the risk of pyelonephritis-induced permanent kidney damage, many children are given long-term (several months to 2 years) antibiotics aimed at preventing recurrence (...) ); detection bias (1); attrition bias (4); reporting bias (6); and other bias (1).Compared to placebo/no treatment, antibiotics lead to a modest decrease in the number of repeat symptomatic UTI in children; however the estimate from combining all studies was not certain and the confidence interval indicates low precision indicating that antibiotics may make little or no difference to risk of repeat infection (RR 0.75, 95% CI 0.28 to 1.98). When we combined only the data from studies with concealed

2019 Cochrane

13. Antibiotic management of urinary tract infection in elderly patients in primary care and its association with bloodstream infections and all cause mortality: population based cohort study. (PubMed)

Antibiotic management of urinary tract infection in elderly patients in primary care and its association with bloodstream infections and all cause mortality: population based cohort study. To evaluate the association between antibiotic treatment for urinary tract infection (UTI) and severe adverse outcomes in elderly patients in primary care.Retrospective population based cohort study.Clinical Practice Research Datalink (2007-15) primary care records linked to hospital episode statistics (...) and death records in England.157 264 adults aged 65 years or older presenting to a general practitioner with at least one diagnosis of suspected or confirmed lower UTI from November 2007 to May 2015.Bloodstream infection, hospital admission, and all cause mortality within 60 days after the index UTI diagnosis.Among 312 896 UTI episodes (157 264 unique patients), 7.2% (n=22 534) did not have a record of antibiotics being prescribed and 6.2% (n=19 292) showed a delay in antibiotic prescribing. 1539

Full Text available with Trip Pro

2019 BMJ

14. Antimicrobial agents for preventing urinary tract infections in adults undergoing cystoscopy. (PubMed)

Antimicrobial agents for preventing urinary tract infections in adults undergoing cystoscopy. Cystoscopy is commonly performed for diagnostic purposes to inspect the interior lining of the bladder. One disadvantage of cystoscopy is the risk of symptomatic urinary tract infection (UTI) due to pre-existing colonization or by introduction of bacteria at the time of the procedure. However, the incidence of symptomatic UTI following cystoscopy is low. Currently, there is no consensus on whether

2019 Cochrane

15. Once-Daily Plazomicin for Complicated Urinary Tract Infections. (PubMed)

Once-Daily Plazomicin for Complicated Urinary Tract Infections. The increasing multidrug resistance among gram-negative uropathogens necessitates new treatments for serious infections. Plazomicin is an aminoglycoside with bactericidal activity against multidrug-resistant (including carbapenem-resistant) Enterobacteriaceae.We randomly assigned 609 patients with complicated urinary tract infections (UTIs), including acute pyelonephritis, in a 1:1 ratio to receive intravenous plazomicin (15 mg per

2019 NEJM

16. Indwelling catheter can increase postoperative urinary tract infection and may not be required in total joint arthroplasty: a meta-analysis of randomized controlled trial

Indwelling catheter can increase postoperative urinary tract infection and may not be required in total joint arthroplasty: a meta-analysis of randomized controlled trial The purpose of this study was to investigate whether patients undergoing total joint arthroplasty (TJA) require catheterization.PubMed, EMBASE, Web of Science, Cochrane Library and China National Knowledge Infrastructure were systematically searched. All randomized controlled trials (RCTs) receiving either a urinary (...) catheterization or no urinary catheterization were included. Meta-analysis results were assessed by RevMan 5.3 software.Seven independent RCTs were included, with a total sample size of 1533 patients, including 750 patients in the indwelling catheter group and 783 patients in the none-indwelling catheter group. Our pooled data analysis indicated that patients in the indwelling catheter group had a higher risk of urinary tract infection than patients in the none-indwelling catheter group (RR, 3.21; P = 0.0003

Full Text available with Trip Pro

2019 EvidenceUpdates

17. Urinary tract infections in women

Urinary tract infections in women Urinary tract infections in women - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Urinary tract infections in women Last reviewed: February 2019 Last updated: January 2019 Summary Can be clinically categorised into uncomplicated/complicated, acute, or recurrent. Escherichia coli is the most common organism in uncomplicated infections. Costovertebral angle tenderness together (...) with fever suggests pyelonephritis. Diagnosed using urine dipstick, microscopic urinalysis (bacteria, white blood cell, red blood cell), and urine culture. Antibiotic selection should be guided by local bacterial susceptibilities and guidelines, or based on known urine culture and sensitivity. Definition A urinary tract infection (UTI) is an infection of the kidneys, bladder, or urethra. Infectious cystitis is the most common type of UTI, which is caused by a bacterial infection of the bladder

2019 BMJ Best Practice

18. Nitrofurantoin is as effective as other long-term antibiotics for preventing recurrent urinary tract infections

Nitrofurantoin is as effective as other long-term antibiotics for preventing recurrent urinary tract infections Nitrofurantoin is as effective as other long-term antibiotics for preventing recurrent urinary tract infections Discover Portal Discover Portal Nitrofurantoin is as effective as other long-term antibiotics for preventing recurrent urinary tract infections Published on 19 December 2016 doi: The antibiotic nitrofurantoin works as well as other long-term antibiotics for preventing (...) recurrent urinary tract infections in women. However gastrointestinal side effects were more common in people on nitrofurantoin. The potential for inducing less antibiotic resistance compared to trimethoprim is a potential advantage of nitrofurantoin but this wasn’t a specified outcome for this review. This review of 12 trials, with 1,063 women, compared nitrofurantoin with other antibiotics such as trimethoprim, or oestrogen cream. It was hoped that this older antibiotic could be a first-line strategy

2019 NIHR Dissemination Centre

19. Daily low-dose antibiotics halve urinary tract infections in people who self-catheterise

Daily low-dose antibiotics halve urinary tract infections in people who self-catheterise Daily low-dose antibiotics halve urinary tract infections in people who self-catheterise Discover Portal Discover Portal Daily low-dose antibiotics halve urinary tract infections in people who self-catheterise Published on 14 August 2018 doi: People who perform clean intermittent self-catheterisation can reduce symptomatic urinary tract infections from two per year to one by taking daily low-dose (...) antibiotics. This NIHR-funded trial randomised 404 adults in the UK who perform the procedure for a variety of reasons to either daily oral low-dose antibiotics or no prophylaxis. All had a recent history of urinary tract infection. Although prophylactic antibiotics halved infection rates, it increased antimicrobial resistance compared with the control group who took short courses of antibiotics for each infection. This has implications for the individual and wider population. As overall reported health

2019 NIHR Dissemination Centre

20. A systematic review of diagnostic test accuracy of dipstick urinalysis to detect urinary tract infection in symptomatic adults

A systematic review of diagnostic test accuracy of dipstick urinalysis to detect urinary tract infection in symptomatic adults Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO